Both in Pharmaceuticals
Viridian Therapeutics vs Schrodinger
Over the past year VRDN returned −7.5% and SDGR returned +51.3%; their daily moves had a correlation of 0.12.
VRDN −7.5% SDGR +51.3%Growth of $1, one year, split-adjusted
| Metric | VRDN | SDGR |
|---|---|---|
| Price | $20.00 | $30.33 |
| Market cap | $2.27B | $2.27B |
| Today | −2.80% | +2.81% |
| 1 month | −13.4% | +54.0% |
| 6 months | +7.9% | +174.0% |
| Year to date | −35.7% | +69.6% |
| 1 year | −1.0% | +57.2% |
| Revenue growth (YoY) | +278.7% | +7.5% |
| Gross margin | 100.0% | 55.1% |
| Net margin | −39726.8% | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | 31.8× | 8.8× |
| Net cash | $625.7M | $413.7M |
| Dividend yield | — | — |
| Volatility (60d) | 45.8% | 74.5% |
| Short % of float | 20.0% | 21.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).